TSS:Hg 102707.1

Basic information about the TSS

---

TSS ID: hg_102707.1 Species: human Chr: chr9		Start: 128771853 End: 128771864 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BC033884 Distance: -29 GeneID: 10444 HGNC/MGI_ID: HGNC:30960 UniProt_ID: Q05BR7

Gene_name: zyg-11 related cell cycle regulator Gene_symbol: ZER1 Gene_synonyms: Hzyg ZYG Gene_source: HGNC:30960

TATA-Box annotation

---

Distance to TSS:	68
Nearest PromoterID:	NM_006336
Entrez ID:	10444
Nearest Unigene:	Hs.147950
Nearest Refseq:	NM_006336
Nearest Ensembl:	ENSG00000160445
Gene Name:	zyg-11 related cell cycle regulator
Gene Alias:	C9orf60|ZYG|ZYG11BL
Gene Description:	zyg-11 related cell cycle regulator
Gene Type:	protein-coding
CpG%:	0.12
GC%:	0.766169
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ZER1 p2@ZER1 p3@ZER1 p4@ZER1
Sample		p1@ZER1	p2@ZER1	p3@ZER1	p4@ZER1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	6.04	1.36	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8.09	1.82	0.00	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	6.37	1.74	0.58	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	6.65	1.87	0.21	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	6.97	1.35	0.22	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	5.04	1.55	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	8.50	1.31	0.00	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	11.63	0.97	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	12.18	1.71	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.33	2.90	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	13.74	2.43	0.81	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	20.33	2.85	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	27.73	3.55	1.13	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	20.60	3.16	0.75	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	24.81	0.88	1.54	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	23.64	1.76	0.75	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	20.09	2.18	1.09	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	24.89	0.84	2.11	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.46	2.13	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	20.61	2.71	1.05	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	18.98	2.27	0.53	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	19.33	2.24	1.55	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	18.10	1.81	0.65	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	17.23	2.43	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	24.51	1.03	0.77	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.47	2.22	0.63	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	18.13	1.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.52	2.59	1.18	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	23.74	2.91	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	22.62	2.17	0.36	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	17.38	1.47	1.26	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	20.32	2.34	1.17	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	16.04	2.32	0.21	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	15.17	1.48	0.33	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	22.44	1.87	1.12	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	23.57	4.02	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	24.32	3.68	1.43	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	20.95	2.01	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	23.23	1.89	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	20.41	3.84	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	21.17	2.82	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	16.25	2.05	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	23.62	4.22	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	22.55	3.67	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	23.69	3.41	0.80	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	20.94	2.79	0.93	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	24.47	2.88	1.20	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	21.46	2.38	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	24.66	2.15	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.62	2.83	0.81	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	15.99	3.69	0.20	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	24.46	4.23	0.89	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	13.84	1.06	2.48	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	14.25	3.98	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	17.62	0.84	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.53	2.30	0.92	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	14.58	3.89	0.97	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	16.06	2.57	1.28	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	23.89	0.63	0.63	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.10	2.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	9.53	1.68	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	31.85	8.76	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	21.07	1.70	0.68	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.22	2.92	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	18.81	2.48	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	10.24	2.93	1.46	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.45	0.99	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.91	1.88	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.55	2.65	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	14.23	2.78	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	14.98	2.75	1.22	0.31
Adipocyte - breast, donor1	11376-118A8	15.68	1.43	0.79	0.16
Adipocyte - breast, donor2	11327-117E4	16.20	2.09	0.96	0.00
Adipocyte - omental, donor1	11473-119C6	17.56	1.91	1.02	0.38
Adipocyte - omental, donor2	11474-119C7	21.68	1.49	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	16.75	3.35	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	9.57	1.28	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.48	1.35	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	26.07	1.39	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	18.97	1.37	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	14.41	2.83	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	17.84	3.07	0.56	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	26.45	5.88	0.59	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	16.89	2.98	1.13	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	15.17	1.29	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	12.80	2.67	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	14.47	1.11	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	19.55	4.99	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	14.57	1.26	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	15.71	2.62	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	16.14	1.22	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	14.59	1.55	0.66	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	15.06	2.87	0.36	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	16.77	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	13.13	1.44	0.18	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	19.93	1.03	0.62	0.00
Anulus Pulposus Cell, donor1	11248-116E6	20.37	1.37	0.46	0.34
Anulus Pulposus Cell, donor2	11463-119B5	22.29	1.96	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	7.19	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	12.16	1.74	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	2.14	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	11.96	1.20	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	7.59	3.79	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.22	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.00	1.62	0.32	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	9.71	1.94	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.94	1.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	11.30	1.88	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	17.42	2.90	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	2.51	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	10.38	1.81	1.65	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	1.36	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	9.20	0.60	0.30	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.18	1.07	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	10.01	1.89	1.32	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	9.62	0.80	0.53	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	8.78	0.00	2.93	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.78	0.66	1.00	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	12.01	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.72	1.37	0.51	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.71	3.40	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	13.28	4.55	0.38	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	8.55	0.57	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	12.61	1.07	1.07	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.42	1.03	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	10.32	1.88	1.41	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.58	2.57	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.85	1.43	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	5.26	2.92	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	13.25	0.90	1.20	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	7.63	1.53	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.66	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	2.54	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	10.36	1.29	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	13.76	1.27	0.85	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	10.15	0.00	0.87	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6.61	1.89	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	10.34	1.36	1.02	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.01	0.86	1.29	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	9.63	0.60	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.21	2.92	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	12.41	0.92	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.12	1.02	0.25	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	12.39	2.68	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.26	1.84	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	10.04	1.91	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	12.42	1.55	0.44	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	0.00	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.86	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	13.24	1.06	0.79	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.81	0.36	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	22.23	2.21	0.86	0.25
Astrocyte - cerebellum, donor2	11580-120F5	29.44	3.59	0.00	0.34
Astrocyte - cerebellum, donor3	11661-122F5	24.54	2.10	0.63	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	14.99	0.70	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	14.40	2.43	0.32	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	18.20	1.49	0.45	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	10.55	0.92	0.23	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	8.90	0.63	0.25	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	8.19	0.57	0.57	0.23
Basophils, donor1	12241-129G9	17.78	1.83	0.52	0.78
Basophils, donor2	12242-129H1	11.91	1.80	0.36	1.44
Basophils, donor3	12243-129H2	10.73	1.91	0.15	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	13.37	1.51	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	24.23	3.66	3.20	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	9.41	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	17.47	1.87	0.62	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	14.74	1.38	0.69	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	12.24	1.44	0.18	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	10.10	0.10	0.10	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	11.88	0.47	0.23	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	16.63	3.84	1.60	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	9.58	1.69	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	10.95	2.23	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	15.59	1.76	0.22	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	16.98	3.68	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	18.95	3.41	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	27.61	3.29	0.99	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	14.74	6.50	0.87	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	9.66	4.83	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	12.56	3.32	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	7.53	1.34	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	6.90	2.48	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	5.21	1.98	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.09	2.15	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.10	1.25	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.88	1.52	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.85	1.64	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	3.70	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	6.66	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	7.59	2.68	0.30	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.79	2.20	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	7.29	1.67	0.00	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.86	1.37	0.46	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.49	0.68	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.67	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	12.64	3.77	1.88	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	7.15	2.79	0.17	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	8.42	2.95	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.86	1.65	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3.87	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1.75	0.88	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	6.45	1.74	0.52	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	2.97	1.12	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	5.39	1.29	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	7.78	2.46	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	2.55	0.70	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1.39	0.93	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	6.54	1.53	0.65	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	11.32	0.69	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	7.36	1.73	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	21.18	2.34	0.62	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	14.32	2.45	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	17.39	2.01	0.67	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	13.27	2.55	0.26	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	12.08	2.20	0.44	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	14.74	2.74	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	16.95	2.71	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	26.93	3.11	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	19.19	3.73	2.13	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	19.83	3.75	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	24.57	4.21	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	23.53	5.49	0.78	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	15.82	2.64	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	27.12	3.29	1.64	0.82
CD19+ B Cells, donor2	11624-122B4	28.29	3.63	2.90	0.73
CD19+ B Cells, donor3	11705-123B4	21.20	5.05	1.51	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	52.53	10.10	1.21	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	49.94	10.39	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	20.08	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	15.17	0.56	2.25	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	19.16	1.50	1.13	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	17.36	1.80	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	33.92	6.43	4.64	2.86
CD4+ T Cells, donor2	11306-117C1	44.70	3.06	2.45	3.06
CD4+ T Cells, donor3	11382-118B5	28.67	6.40	1.52	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	19.40	4.08	2.04	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	20.21	5.39	1.35	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	26.73	6.61	4.02	3.16
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	30.82	5.22	2.84	5.22
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	37.22	2.81	5.62	6.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	16.48	6.59	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	18.21	3.47	1.88	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	17.12	4.74	1.69	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	17.73	3.22	1.61	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	18.83	8.07	1.34	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	27.60	4.19	2.45	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	22.00	5.72	2.20	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	19.82	5.06	3.37	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	20.15	3.74	1.45	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	15.70	4.01	3.68	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	39.43	7.07	5.98	4.08
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	45.02	8.04	5.90	5.90
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	43.04	16.14	5.38	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	17.62	4.08	0.37	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	16.90	4.33	1.52	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	25.43	3.36	1.05	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	17.70	2.53	3.03	4.04
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	19.06	4.33	2.17	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	26.58	6.10	2.18	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	35.14	6.43	2.97	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	24.93	1.85	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	23.73	1.40	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	26.59	5.82	1.38	3.60
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	44.17	8.10	1.96	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	47.74	12.32	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	42.62	5.73	1.79	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	38.78	8.31	4.15	1.38
CD8+ T Cells, donor1	11226-116C2	31.10	6.22	0.98	0.65
CD8+ T Cells, donor2	11307-117C2	25.53	4.13	3.00	2.63
CD8+ T Cells, donor3	11383-118B6	45.20	9.59	5.55	2.78
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.05	1.38	0.23	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.27	1.68	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	6.02	0.55	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1.80	1.50	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.88	1.68	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	6.14	2.50	0.91	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.65	2.39	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	2.90	2.37	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	5.86	2.81	0.47	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.04	1.21	1.21	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	2.61	0.87	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	5.86	2.40	0.00	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	6.57	2.63	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	4.10	4.55	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	10.44	4.48	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	9.36	1.44	0.72	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.32	2.59	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	5.89	1.65	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	9.19	1.58	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	7.38	0.92	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.13	2.89	0.96	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	4.59	2.29	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	5.12	0.79	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	1.51	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	7.23	5.62	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	14.69	3.50	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	16.03	6.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	20.11	1.83	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	8.40	1.98	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	11.89	0.74	0.95	0.21
Chondrocyte - de diff, donor1	11261-116G1	17.33	1.04	1.39	0.69
Chondrocyte - de diff, donor2	11338-117F6	12.08	1.42	1.07	1.07
Chondrocyte - de diff, donor3	11410-118E6	12.63	1.82	1.02	0.11
Chondrocyte - re diff, donor2	11339-117F7	12.53	0.90	1.79	1.79
Chondrocyte - re diff, donor3	11411-118E7	18.60	2.43	2.02	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	18.13	1.26	0.46	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	15.18	1.50	0.64	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	18.32	2.57	0.97	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	72.72	7.70	3.39	1.47
Corneal Epithelial Cells, donor1	11526-119I5	17.13	1.54	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	17.06	0.00	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	16.36	1.79	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	14.53	4.46	3.47	2.48
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	12.93	6.31	3.15	2.21
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	6.90	6.90	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	9.94	3.46	1.08	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	12.64	2.73	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	9.14	1.96	1.31	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	9.68	2.42	0.00	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	8.34	1.17	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	5.28	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	9.90	2.26	0.85	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	14.15	2.36	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	9.31	2.33	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	11.06	1.18	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	10.52	1.93	0.70	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	9.53	2.22	1.11	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	9.74	3.35	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	9.58	1.69	0.85	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	12.78	2.08	0.59	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	5.21	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	13.04	1.56	0.57	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	8.40	1.20	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	7.34	1.57	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	14.54	1.62	0.50	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	17.38	2.61	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	15.63	1.83	0.37	0.00
Endothelial Cells - Vein, donor1	11267-116G7	7.96	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	3.49	2.79	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	11.15	1.88	0.31	0.00
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	120.47	6.60	3.30	8.25
Eosinophils, donor3	12246-129H5	60.64	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	11.48	1.22	0.73	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	20.80	6.24	4.16	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	20.94	0.82	1.64	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	10.40	1.20	0.44	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	15.49	1.19	0.33	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	13.70	1.09	0.61	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	17.06	1.23	0.96	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	21.52	2.11	0.63	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	12.38	0.79	0.53	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	15.61	1.33	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	17.24	0.45	0.45	2.27
Fibroblast - Cardiac, donor2	11345-117G4	9.10	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	13.72	1.10	0.47	0.16
Fibroblast - Cardiac, donor4	11452-119A3	17.58	3.33	0.30	0.61
Fibroblast - Cardiac, donor5	11456-119A7	15.10	1.90	0.76	0.13
Fibroblast - Cardiac, donor6	11460-119B2	15.01	2.43	1.21	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	21.04	2.68	1.34	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	20.28	3.45	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	27.45	1.61	0.92	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	26.63	2.71	1.53	0.00
Fibroblast - Dermal, donor1	11269-116G9	11.74	1.17	0.70	0.70
Fibroblast - Dermal, donor2	11346-117G5	8.02	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	11.73	2.54	0.97	0.24
Fibroblast - Dermal, donor4	11450-119A1	10.06	0.90	0.11	0.23
Fibroblast - Dermal, donor5	11454-119A5	8.72	0.52	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	11.53	0.16	0.00	0.32
Fibroblast - Gingival, donor1	11237-116D4	16.03	1.25	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	27.51	2.62	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	14.63	0.53	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	20.79	2.03	0.39	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	23.89	1.04	1.04	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	21.50	2.11	0.35	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	19.49	2.03	0.31	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	14.33	1.35	0.27	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	48.70	4.59	0.35	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	22.52	2.92	0.44	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	22.09	1.91	0.55	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	11.96	0.99	0.44	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	26.41	4.26	0.88	0.15
Fibroblast - Lung, donor1	11270-116H1	6.80	1.36	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	10.45	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	13.51	1.27	1.48	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	31.65	1.67	2.50	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	13.99	2.80	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	19.87	2.52	1.12	0.56
Fibroblast - Mammary, donor1	11540-120B1	27.20	1.22	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	35.95	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	10.09	0.78	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	16.99	0.46	0.46	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	19.58	1.22	0.61	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	18.32	2.67	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.55	1.35	0.54	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	22.85	2.67	1.62	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	8.73	0.99	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	21.94	3.25	0.81	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	22.05	3.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	8.30	0.79	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	14.49	1.59	0.60	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	11.90	1.42	0.89	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	12.81	1.58	1.38	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	16.25	2.11	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	15.55	2.16	0.43	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	23.28	3.29	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	18.70	2.63	0.66	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	19.85	2.01	0.80	0.60
Fibroblast - skin normal, donor2	11561-120D4	16.27	1.81	0.60	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	25.09	1.81	0.91	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	19.97	3.07	0.75	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	17.78	3.76	0.51	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	21.68	1.31	0.33	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	16.30	1.81	0.43	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	15.01	2.02	1.18	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	10.98	1.57	0.31	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	23.53	1.74	1.74	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	13.18	1.91	0.69	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	15.61	0.78	0.78	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	15.08	1.79	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	13.78	2.30	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	11.49	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	14.55	0.86	1.14	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	43.29	1.38	0.83	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	32.88	2.05	0.91	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	24.17	2.38	0.20	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	40.71	1.32	1.59	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	34.57	4.89	1.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	15.04	3.54	0.00	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	14.13	2.26	1.27	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	17.49	2.59	0.25	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	12.09	2.15	0.54	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	13.26	2.11	0.99	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	11.49	1.38	1.25	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	12.40	1.83	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	18.71	2.05	0.23	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	17.19	1.74	0.75	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	18.36	2.40	1.31	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	19.21	3.84	0.30	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	19.87	2.07	0.79	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	20.11	2.46	0.45	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	18.95	2.22	1.21	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	14.93	1.36	0.85	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	18.44	1.77	1.33	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.12	2.19	1.56	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	23.74	2.56	0.51	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	16.93	1.99	0.55	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	16.72	1.91	0.42	1.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.36	1.84	0.00	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	15.68	2.68	1.44	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.64	3.34	0.35	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	17.01	3.67	1.17	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	22.92	2.87	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	23.49	1.97	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	15.24	2.59	0.16	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	24.37	1.28	1.28	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.14	2.94	0.57	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	17.56	2.06	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	22.81	2.43	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	17.56	3.35	0.73	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	20.20	2.20	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	23.29	3.37	1.12	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	16.57	2.78	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.72	1.60	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	15.30	1.53	0.61	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	10.62	2.46	0.39	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	17.89	2.44	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	21.38	1.84	1.29	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	23.47	2.85	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	42.65	4.96	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	17.81	2.51	0.26	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	13.52	3.63	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	45.75	3.30	1.52	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	12.74	1.39	0.80	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	15.87	2.77	0.92	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	12.48	2.05	1.23	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	9.70	1.25	0.31	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.89	0.85	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	12.91	1.38	0.92	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	13.93	1.55	1.16	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	0.00	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	17.39	6.96	1.74	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	11.39	1.95	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	10.30	1.24	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	12.58	1.68	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	11.11	1.31	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	9.23	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	18.45	1.59	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	11.21	2.38	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	8.35	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	10.31	0.57	0.57	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	13.91	1.18	0.30	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	11.86	1.69	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	9.11	2.90	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.74	2.76	0.46	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	8.84	3.08	0.38	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	8.80	1.63	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	10.03	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	16.57	2.31	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	15.06	2.74	0.68	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	0.00	2.48	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	20.76	1.42	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	12.07	1.21	0.60	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	21.87	2.03	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	18.35	3.19	1.20	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.31	2.47	0.99	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	15.35	1.18	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	14.00	2.33	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	21.51	3.07	3.07	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	19.50	1.70	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	14.33	2.39	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	8.73	1.94	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	19.96	3.33	1.25	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	1.12	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.32	2.85	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	12.95	1.25	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	11.72	0.70	0.23	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	10.30	1.69	0.51	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	7.51	0.91	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	9.84	1.09	0.11	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	7.95	1.29	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.33	0.43	0.65	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	8.84	0.62	0.12	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	7.89	1.20	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.41	1.28	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	12.31	3.92	2.24	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	15.58	2.60	1.30	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	0.00	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	19.05	1.76	1.06	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	23.97	2.91	1.45	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	8.22	1.40	0.17	0.00
Hepatocyte, donor1	11523-119I2	14.53	3.63	0.00	1.21
Hepatocyte, donor2	11603-120I1	4.31	2.15	0.00	0.00
Hepatocyte, donor3	11684-122I1	14.72	2.45	0.61	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	11.75	2.61	1.96	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	13.63	2.27	1.75	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	8.92	1.37	2.06	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	6.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	13.35	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	19.49	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	23.82	3.97	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	11.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	13.23	0.63	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	9.04	1.29	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	14.49	6.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	7.33	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	11.75	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	13.66	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.00	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	7.55	0.94	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	8.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	15.07	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	11.48	0.64	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	9.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	15.00	2.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.33	0.62	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	15.80	3.51	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	8.34	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	22.13	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	32.26	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	4.50	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	16.00	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	4.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	16.57	3.68	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	6.21	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	27.49	3.17	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	15.26	1.22	0.98	0.16
Keratinocyte - epidermal, donor2	11349-117G8	8.78	2.34	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	8.42	1.23	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	21.91	1.36	1.36	0.68
Keratocytes, donor1	11527-119I6	31.63	2.75	1.03	0.00
Keratocytes, donor2	11607-120I5	16.41	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	24.70	1.98	0.20	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	37.36	8.79	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	9.71	1.08	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	20.30	1.73	0.92	0.46
Lens Epithelial Cells, donor3	11690-122I7	15.54	1.51	1.01	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.50	2.73	0.71	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.26	1.12	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	10.70	1.42	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.07	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	10.72	1.89	0.32	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.68	1.08	0.65	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.16	2.05	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.12	1.52	0.25	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	10.27	0.70	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.70	0.79	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.14	0.19	0.97	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.00	1.30	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	7.67	0.35	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.59	0.95	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.06	1.10	0.96	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	6.16	0.92	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.48	0.94	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	9.52	0.91	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	10.20	1.65	0.33	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.37	0.88	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	11.45	1.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.27	1.45	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	6.73	0.81	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.78	1.67	0.61	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.78	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	8.38	1.88	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.17	1.65	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	5.50	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.64	1.13	0.56	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.65	1.17	0.95	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.72	0.97	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.62	0.33	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.05	1.73	0.62	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	9.63	0.74	1.11	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.93	0.99	0.25	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	11.82	1.10	0.55	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.68	1.93	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.00	0.91	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.94	0.98	0.98	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	4.98	1.42	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.30	0.48	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	8.87	1.24	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.52	2.51	0.72	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	4.90	1.63	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.24	1.18	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	11.63	1.86	1.86	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.12	0.77	0.77	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.95	3.58	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	31.45	6.90	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	25.24	6.68	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	29.62	3.39	2.54	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	19.69	2.81	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.02	0.93	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	18.03	4.12	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	29.74	5.95	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	21.49	3.85	2.71	1.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	19.49	4.07	2.33	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	18.46	3.60	2.70	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	28.72	4.34	3.39	1.22
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	25.68	5.65	1.54	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	25.05	6.70	2.12	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	13.33	3.33	0.67	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	25.98	4.08	2.04	3.57
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	21.61	3.74	4.27	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	30.23	5.67	1.13	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	25.77	4.29	1.23	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	37.51	10.60	2.45	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	25.41	4.16	2.92	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	21.58	4.20	1.68	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	32.97	9.27	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	22.35	2.90	1.45	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	19.43	3.59	1.20	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	24.34	3.32	1.66	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	31.81	8.13	1.41	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.18	5.16	1.84	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	8.06	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	25.33	6.52	2.69	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	22.08	3.40	5.10	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	24.61	8.20	4.10	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	25.31	5.87	1.81	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.11	3.59	1.44	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	21.66	3.73	2.24	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	26.75	6.32	3.72	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.52	5.17	2.58	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	21.41	6.85	1.71	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	22.66	5.00	2.00	2.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	30.77	4.83	0.60	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	20.62	5.69	4.98	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	31.97	4.12	4.12	2.75
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	22.54	9.66	3.22	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	23.57	8.08	0.67	4.71
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	28.89	4.07	3.70	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	10.47	1.16	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	29.62	5.29	4.23	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	29.21	5.60	3.60	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	32.71	5.81	2.18	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	32.19	9.96	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	33.54	5.43	2.47	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	28.23	5.65	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	33.69	8.55	2.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	35.15	4.96	3.60	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	3.44	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	23.16	7.57	2.67	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	25.42	4.69	2.35	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	31.01	5.94	1.98	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	28.02	7.78	1.04	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	35.88	7.88	1.31	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	26.28	8.95	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	22.08	6.18	2.65	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	27.39	3.09	3.47	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	32.91	6.08	2.53	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	22.11	6.73	2.88	3.36
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	28.23	3.18	1.99	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	22.48	5.47	1.22	5.47
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	16.60	5.53	2.77	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	30.78	4.18	1.52	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	22.21	2.58	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	19.95	4.23	4.23	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	27.57	4.75	2.54	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	23.99	8.00	3.20	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	22.99	5.17	2.87	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	25.71	3.60	4.11	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.17	6.37	2.83	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	27.81	5.67	3.40	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.46	7.90	2.50	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	20.36	2.35	1.57	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	19.21	5.43	2.09	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	25.09	6.04	2.32	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	15.39	7.36	4.01	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	17.64	4.28	2.14	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	23.84	4.85	2.42	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.94	3.67	2.75	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	14.23	5.33	2.67	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	20.52	9.69	4.56	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.10	5.37	4.60	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.04	3.28	2.74	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	20.49	7.57	2.67	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	14.30	5.46	2.86	2.60
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	19.23	8.62	5.97	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	2.08	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	9.80	2.05	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	5.14	0.37	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	9.83	1.97	0.66	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3.19	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	10.30	0.95	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	8.20	0.28	0.28	0.14
Mammary Epithelial Cell, donor1	11273-116H4	10.86	0.40	0.50	0.00
Mammary Epithelial Cell, donor2	11350-117G9	8.98	0.87	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	11.97	0.75	0.50	0.75
Mast cell - stimulated, donor1	11487-119E2	4.07	1.36	2.03	0.68
Mast cell, donor1	11563-120D6	26.71	5.41	1.73	1.41
Mast cell, donor2	11565-120D8	39.82	4.75	1.19	1.78
Mast cell, donor3	11566-120D9	49.53	6.98	3.83	1.35
Mast cell, donor4	11567-120E1	53.36	5.67	2.48	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	30.61	11.53	7.65	5.32
Mast cell, expanded and stimulated, donor8	11942-126A7	26.85	7.00	8.17	7.00
Mast cell, expanded, donor5	11939-126A4	18.81	4.93	0.92	0.69
Mast cell, expanded, donor8	11941-126A6	62.09	11.21	3.68	1.84
Melanocyte - dark, donor1	11502-119F8	12.74	1.39	0.20	0.20
Melanocyte - dark, donor2	11582-120F7	9.69	1.38	1.04	0.69
Melanocyte - dark, donor3	11663-122F7	14.49	1.59	0.00	0.07
Melanocyte - light, donor1	11274-116H5	20.69	1.88	0.71	0.00
Melanocyte - light, donor2	11351-117H1	19.11	6.14	0.00	0.00
Melanocyte - light, donor3	11423-118G1	12.14	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	9.48	0.83	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	10.22	0.81	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	20.36	2.14	0.00	0.54
Meningeal Cells, donor1	11493-119E8	17.24	1.36	0.74	0.12
Meningeal Cells, donor2	11573-120E7	15.41	2.20	1.76	3.08
Meningeal Cells, donor3	11654-122E7	10.60	0.65	0.49	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	17.11	0.86	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.87	1.91	0.40	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	32.85	3.94	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	30.09	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.89	2.15	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	11.22	2.33	0.85	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	18.60	2.01	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	13.84	1.98	0.88	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	11.69	0.73	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.50	1.43	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	14.68	0.97	0.28	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	23.79	2.60	1.86	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	16.18	0.92	1.45	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	21.37	0.89	0.30	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	23.69	2.56	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	9.22	0.71	0.00	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	15.01	1.88	1.25	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	8.71	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	13.26	2.92	1.33	0.27
Mesothelial Cells, donor2	12156-128G5	14.51	2.50	0.50	1.00
Mesothelial Cells, donor3	11402-118D7	15.97	2.02	1.23	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	13.50	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	10.34	1.97	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	11.48	1.47	2.06	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	7.13	1.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	7.26	1.04	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	8.26	1.50	1.50	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	10.71	1.86	1.40	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	4.88	2.03	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	8.32	2.38	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	10.62	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.26	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	6.37	1.27	0.85	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	6.26	1.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	3.76	1.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.18	1.66	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	2.21	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	2.53	0.00	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.47	0.42	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	4.28	0.82	0.61	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.43	0.86	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5.56	2.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2.19	1.10	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.58	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1.63	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	6.18	0.88	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	2.00	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.31	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	4.48	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	2.73	0.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	3.48	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	2.21	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.15	2.05	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.06	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	6.04	2.49	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3.37	1.12	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.91	1.25	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.91	1.17	0.58	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	3.02	1.21	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	1.67	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	1.85	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	12.52	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	6.49	1.38	0.28	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	6.22	1.04	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.44	1.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	1.91	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	8.01	0.53	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.87	3.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	8.90	1.98	0.28	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	5.10	0.96	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	12.38	2.65	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.51	3.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	8.52	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	9.59	1.97	0.98	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.73	5.87	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	12.06	3.23	0.59	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	16.15	4.90	0.86	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	19.78	2.06	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	12.51	2.98	0.30	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	8.87	0.99	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	7.36	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.71	1.58	0.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	9.31	3.73	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	5.63	1.50	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	4.79	1.86	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.88	1.70	0.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.60	2.56	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	7.78	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.21	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	4.04	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1.26	0.84	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	9.50	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	12.06	2.37	0.43	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	18.29	3.14	1.05	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	13.35	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	20.87	2.92	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	31.56	3.23	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	31.92	4.79	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.28	2.04	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	11.03	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.83	0.84	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	23.71	2.32	0.70	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.08	3.24	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	25.23	3.36	1.05	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	15.39	2.48	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	20.03	1.89	0.81	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	25.84	2.72	1.36	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	24.82	3.76	1.96	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	21.69	2.19	1.09	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.97	1.59	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	15.61	3.60	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	36.76	2.30	0.33	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	26.83	3.42	0.49	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	20.11	3.70	0.88	1.23
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	22.50	5.63	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	21.15	0.46	0.92	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	21.21	3.53	0.96	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	37.59	2.07	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	32.87	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	20.72	4.46	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.02	2.54	1.27	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.36	3.32	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.46	3.43	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	23.66	4.67	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	23.90	3.16	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	16.27	1.98	2.38	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.00	2.79	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.41	4.16	0.76	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	24.77	2.28	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	20.05	1.74	1.74	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.19	2.26	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	10.58	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	15.29	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	17.86	2.48	0.50	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	21.82	4.59	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	24.50	3.93	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	17.90	3.98	1.33	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	15.59	5.42	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	16.46	3.05	0.00	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	24.55	5.04	0.94	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	22.70	4.24	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.94	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	54.41	3.40	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	10.93	0.37	0.99	0.25
Myoblast, donor2	11322-117D8	16.11	1.34	0.77	0.19
Myoblast, donor3	11398-118D3	14.80	1.35	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	14.59	1.31	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	30.75	4.92	1.23	1.54
Natural Killer Cells, donor2	11311-117C6	27.44	3.62	4.52	2.41
Natural Killer Cells, donor3	11387-118C1	32.03	4.97	3.13	1.47
Neural stem cells, donor1	11275-116H6	28.31	2.90	0.36	0.36
Neural stem cells, donor2	11352-117H2	34.66	1.93	0.00	0.00
Neurons, donor1	11494-119E9	20.48	4.55	0.00	0.00
Neurons, donor2	11574-120E8	29.72	3.08	0.44	0.22
Neurons, donor3	11655-122E8	12.33	1.64	1.64	0.00
Neutrophils, donor1	11233-116C9	70.53	9.28	3.71	0.93
Neutrophils, donor2	11314-117C9	75.37	14.49	8.70	2.90
Neutrophils, donor3	11390-118C4	130.11	19.55	3.05	3.67
Nucleus Pulposus Cell, donor1	11252-116F1	23.15	1.78	0.47	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	27.03	1.30	1.30	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	14.04	1.80	1.40	0.40
Olfactory epithelial cells, donor1	11933-125I7	17.21	3.17	0.55	0.41
Olfactory epithelial cells, donor2	11934-125I8	15.92	1.88	0.58	0.00
Olfactory epithelial cells, donor3	11935-125I9	16.34	1.93	1.02	0.00
Olfactory epithelial cells, donor4	11936-126A1	24.54	3.21	0.88	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	15.05	1.81	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	18.08	0.85	0.43	0.64
Osteoblast - differentiated, donor2	11353-117H3	14.86	4.57	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	16.14	1.24	1.24	0.00
Osteoblast, donor1	11277-116H8	27.17	2.93	0.20	0.59
Osteoblast, donor2	11354-117H4	10.53	2.11	1.40	0.00
Osteoblast, donor3	11426-118G4	23.64	3.38	1.24	0.53
Pancreatic stromal cells, donor1	11249-116E7	13.65	1.26	0.42	0.25
Pericytes, donor1	11491-119E6	36.94	3.56	0.78	0.33
Pericytes, donor2	11571-120E5	34.41	5.21	2.04	0.00
Pericytes, donor3	11652-122E5	15.46	2.44	0.20	0.61
Perineurial Cells, donor1	11499-119F5	14.13	0.90	0.79	0.45
Perineurial Cells, donor2	11579-120F4	14.45	1.47	1.01	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	23.27	3.82	2.87	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	14.69	1.71	2.45	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	22.52	4.27	0.91	1.29
Placental Epithelial Cells, donor1	11278-116H9	20.81	1.91	0.72	0.48
Placental Epithelial Cells, donor2	11355-117H5	18.85	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	13.94	1.18	0.39	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	15.19	1.90	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	16.51	1.50	0.94	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	17.75	2.22	0.52	0.13
Preadipocyte - breast, donor2	11328-117E5	16.89	2.48	1.35	0.45
Preadipocyte - omental, donor1	11468-119C1	19.61	2.13	0.75	0.64
Preadipocyte - omental, donor2	11329-117E6	17.90	1.31	2.18	1.31
Preadipocyte - omental, donor3	11403-118D8	21.34	1.58	0.43	0.29
Preadipocyte - perirenal, donor1	11469-119C2	18.70	1.97	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	13.82	1.23	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	12.57	0.89	0.18	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	12.60	1.19	1.19	0.17
Preadipocyte - visceral, donor1	11280-116I2	13.69	1.02	0.65	0.28
Preadipocyte - visceral, donor2	11357-117H7	14.27	1.84	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	11.08	1.36	0.52	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	9.35	1.51	0.00	0.45
Prostate Epithelial Cells, donor2	11331-117E8	22.07	1.35	1.76	0.41
Prostate Epithelial Cells, donor3	11404-118D9	13.59	1.59	0.24	0.12
Prostate Stromal Cells, donor1	11254-116F3	13.78	1.25	0.80	0.11
Prostate Stromal Cells, donor2	11332-117E9	14.16	1.97	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	20.23	2.40	0.94	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	19.71	1.46	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	14.42	0.83	0.83	0.62
Renal Epithelial Cells, donor1	11517-119H5	27.39	1.52	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	15.65	1.42	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	16.41	1.06	0.95	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	11.57	2.72	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	12.67	1.62	0.81	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	12.21	1.78	0.44	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.31	5.99	2.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	22.45	1.54	1.32	0.22
Renal Mesangial Cells, donor2	11598-120H5	16.93	2.51	1.25	0.63
Renal Mesangial Cells, donor3	11679-122H5	24.13	2.50	0.83	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	12.08	0.27	0.54	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	12.23	0.84	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	15.43	1.54	0.96	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	12.70	1.04	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	21.32	0.85	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	18.07	1.00	1.51	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	24.72	4.54	2.27	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	21.44	5.36	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	12.11	3.30	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	17.98	0.58	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	14.56	2.08	0.26	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	15.29	1.69	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	14.17	2.01	0.89	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	13.15	1.36	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	18.30	1.98	0.82	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	15.95	3.93	1.39	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	14.92	2.88	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	14.82	1.82	0.45	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	14.87	2.33	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	15.35	2.87	0.29	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	13.63	2.25	0.64	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	13.72	2.66	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	14.91	2.87	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	14.63	2.24	0.47	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	18.04	2.07	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	16.19	2.92	1.06	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	15.48	2.53	0.39	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	17.38	2.48	1.34	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	15.06	2.35	0.75	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	17.66	1.96	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	14.36	1.20	0.85	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	15.13	3.65	0.73	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	14.10	1.96	0.61	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	13.97	3.09	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	17.22	2.12	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	13.29	1.59	1.19	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	18.47	2.57	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	12.65	3.11	0.62	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	16.81	1.99	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	21.93	3.76	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	14.94	2.02	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	22.31	2.21	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	16.19	1.93	0.19	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	17.54	3.09	0.34	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	19.34	3.29	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	18.72	3.61	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	17.21	4.43	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	17.02	2.22	0.44	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	18.66	2.13	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	23.51	3.87	0.41	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	17.62	2.62	0.48	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	24.99	3.83	0.81	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	19.31	2.83	1.13	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	18.17	2.45	1.75	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	21.15	3.02	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.34	6.00	1.35	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	31.29	6.55	1.60	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	28.60	4.87	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	18.99	6.03	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	22.17	3.39	0.90	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	24.86	5.39	0.90	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	25.27	4.01	0.94	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	28.39	4.06	0.64	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	19.23	4.81	0.60	0.00
Schwann Cells, donor1	11498-119F4	24.07	1.13	0.19	0.19
Schwann Cells, donor2	11578-120F3	10.21	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	16.65	1.10	0.22	0.00
Sebocyte, donor1	11220-116B5	26.84	3.29	1.64	0.55
Sebocyte, donor2	11301-117B5	18.84	1.84	0.00	1.38
Sebocyte, donor3	11378-118B1	28.65	2.27	0.21	0.21
Sertoli Cells, donor1	11255-116F4	18.22	4.97	0.00	0.00
Sertoli Cells, donor2	11333-117F1	28.24	0.00	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	19.71	1.32	0.62	0.18
Skeletal Muscle Cells, donor2	11358-117H8	20.24	4.34	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	17.56	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	12.41	0.94	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	13.68	1.19	0.00	0.15
Skeletal Muscle Cells, donor6	11459-119B1	11.85	1.23	0.46	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	14.99	1.01	0.13	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.12	1.14	0.29	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	12.10	1.49	0.10	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	22.66	2.19	0.93	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	16.65	2.17	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	18.85	2.34	1.24	0.83
Skin - palm, donor1	10286-104F7	45.66	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.39	1.73	0.86	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	22.90	2.45	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.61	1.04	0.65	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	10.01	1.11	1.25	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	14.63	2.53	1.13	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	20.09	3.17	1.27	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	15.51	3.52	2.47	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	13.58	4.01	0.31	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	13.12	2.00	0.44	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.70	1.76	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	26.74	2.21	0.88	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.14	0.79	1.18	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	19.31	2.32	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	20.02	1.00	3.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	16.10	1.46	1.20	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	10.86	1.33	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	10.75	1.15	0.38	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.33	0.65	1.30	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	15.95	1.48	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.24	1.42	0.71	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	16.92	2.44	0.98	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	18.87	3.04	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	21.97	1.77	0.76	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	12.24	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	15.74	2.38	2.38	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	12.98	0.74	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	14.21	0.65	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	14.48	1.47	0.63	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	15.93	1.39	0.77	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	22.64	2.16	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	14.94	0.90	1.20	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	19.12	2.39	1.37	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	17.35	2.75	0.94	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	28.98	2.92	1.11	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	11.15	1.82	0.91	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	15.10	5.43	1.21	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	9.54	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	14.78	1.86	1.07	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	24.42	1.50	1.38	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	18.01	1.27	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	16.13	1.36	0.30	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	24.76	3.75	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	148.60	24.55	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	28.83	2.79	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	24.74	4.54	2.52	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	19.43	3.45	1.88	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	18.88	2.65	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	15.16	0.83	0.25	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	28.03	3.27	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	12.38	2.01	1.01	0.86
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	10.45	0.76	1.78	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	11.85	0.94	0.75	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.44	0.70	0.28	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	12.65	0.84	0.17	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	15.24	2.38	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	13.21	2.69	0.73	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	18.34	1.77	1.10	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	14.34	1.17	0.88	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	18.08	2.53	0.58	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	12.69	1.59	0.79	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	8.93	1.12	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	16.17	1.80	1.08	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	12.49	1.70	0.57	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.63	0.79	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	11.94	1.27	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	19.97	3.59	1.20	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	19.23	1.67	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	14.67	4.58	0.00	0.00
Synoviocyte, donor1	11291-117A4	14.98	2.19	1.18	0.84
Synoviocyte, donor2	11368-117I9	17.10	2.35	1.34	0.17
Synoviocyte, donor3	11440-118H9	15.19	4.24	0.89	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	18.58	2.14	0.71	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	3.96	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	21.30	2.08	0.93	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	10.54	0.50	0.43	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	13.53	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.74	1.15	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	22.76	2.83	1.60	0.74
Urethra, donor2	10319-105A4	39.57	3.60	1.80	1.80
Urothelial Cells, donor1	11520-119H8	14.61	1.59	0.27	1.33
Urothelial Cells, donor2	11600-120H7	20.83	1.60	0.80	0.00
Urothelial Cells, donor3	11681-122H7	16.96	2.06	0.46	0.46
Urothelial cells, donor0	11216-116B1	19.17	0.89	1.78	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	274.94	80.97	14.24	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	300.22	68.62	12.87	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	224.52	54.76	9.58	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	122.24	27.89	4.82	2.75
Whole blood (ribopure), donor090325, donation2	12177-128I8	126.66	24.40	4.65	3.49
Whole blood (ribopure), donor090612, donation1	12182-129A4	218.66	62.47	7.29	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	240.46	68.83	6.42	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	242.83	41.08	10.95	3.65
Wilms' tumor cell line:G-401	10809-111A8	13.57	1.97	1.36	1.36
Wilms' tumor cell line:HFWT	10597-108E3	27.28	4.40	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	12.29	0.84	0.28	0.00
achilles tendon, donor2	10292-104G4	10.33	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	6.88	1.02	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	12.77	0.93	0.46	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	27.07	1.90	1.31	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	14.15	0.54	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	9.56	0.56	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	14.38	2.96	0.85	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	9.80	1.36	0.54	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	12.34	2.20	0.00	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	12.25	2.04	2.04	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	18.64	2.33	1.16	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	5.89	1.10	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	11.70	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	10.46	1.63	0.46	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	18.38	4.40	0.00	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	12.57	0.29	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	10.22	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	9.05	2.06	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	5.83	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	11.52	0.85	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	9.40	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	7.94	1.20	0.72	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	5.12	0.22	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	12.01	2.33	2.00	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	39.02	1.86	1.86	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	12.81	1.13	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	21.37	4.36	0.87	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	41.24	9.37	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	7.54	1.18	0.47	0.24
adipose tissue, adult, pool1	10010-101C1	20.79	3.26	1.71	0.47
adipose, donor1	10184-103D4	25.22	0.00	0.00	0.00
adipose, donor2	10185-103D5	40.96	2.03	0.41	0.81
adipose, donor3	10186-103D6	32.95	1.63	1.09	0.54
adipose, donor4	10187-103D7	12.13	3.47	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	11.21	0.95	0.47	0.00
adrenal gland, adult, pool1	10081-102A9	18.19	3.64	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	15.21	1.07	0.27	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	16.44	3.57	0.36	2.14
amniotic membrane cells, donor1	12235-129G3	18.55	2.32	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	22.31	4.06	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	22.10	2.36	1.18	0.00
amygdala - adult, donor10196	10167-103B5	84.19	14.23	2.37	1.19
amygdala, adult, donor10252	10151-102I7	120.24	18.05	11.56	4.26
amygdala, newborn, donor10223	10360-105E9	40.02	6.78	2.26	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	34.25	4.46	2.93	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	11.03	0.88	0.22	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	29.40	7.01	0.67	1.34
aorta, adult, pool1	10052-101G7	29.22	5.10	1.18	0.98
appendix, adult	10189-103D9	25.23	3.49	2.72	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	19.60	3.10	0.69	0.69
artery, adult	10190-103E1	46.20	6.79	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	29.41	5.65	0.87	0.87
b cell line:RPMI1788	10427-106D4	12.49	1.04	0.45	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	18.31	1.66	1.39	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	14.09	1.39	0.50	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	10.54	0.17	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	17.34	2.80	0.00	0.00
bladder, adult, pool1	10011-101C2	36.07	3.91	2.17	0.87
blood, adult, pool1	10053-101G8	170.53	55.37	4.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	15.41	1.71	0.00	0.00
bone marrow, adult	10192-103E3	22.94	4.72	2.70	1.35
brain, adult, donor1	10084-102B3	80.98	10.25	4.10	1.03
brain, adult, pool1	10012-101C3	86.30	9.80	3.45	2.34
brain, fetal, pool1	10085-102B4	74.80	16.03	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	43.28	2.64	0.99	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	24.47	4.37	1.87	0.50
breast, adult, donor1	10080-102A8	19.57	5.68	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	6.35	0.64	0.51	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	19.17	4.33	1.86	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	5.53	0.92	0.46	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	20.09	2.18	0.48	0.24
carcinoid cell line:NCI-H1770	10703-109H1	9.87	0.47	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	20.45	2.19	0.33	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	16.48	0.63	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	13.04	1.60	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	64.47	4.61	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	84.17	15.56	9.04	2.34
caudate nucleus, adult, donor10258	10379-105H1	62.66	4.58	8.41	1.53
caudate nucleus, newborn, donor10223	10354-105E3	39.19	6.96	1.83	1.83
cerebellum - adult, donor10196	10173-103C2	75.75	11.65	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	137.29	18.15	5.55	1.07
cerebellum, adult, pool1	10083-102B2	58.99	6.21	2.41	0.69
cerebellum, newborn, donor10223	10357-105E6	76.39	9.13	0.83	0.83
cerebral meninges, adult	10188-103D8	74.89	10.34	2.77	2.02
cerebrospinal fluid, donor2	10294-104G6	26.31	5.12	0.73	1.46
cervical cancer cell line:D98-AH2	10552-107I3	29.33	1.73	0.58	0.29
cervical cancer cell line:ME-180	10553-107I4	33.47	5.47	2.98	0.17
cervix, adult, pool1	10013-101C4	40.84	3.99	2.73	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	16.72	3.07	0.42	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	26.13	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	18.02	0.87	0.37	0.62
choriocarcinoma cell line:SCH	10785-110H2	14.42	1.85	0.37	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	15.42	0.47	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	17.67	1.14	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	23.57	2.39	1.39	0.20
chorionic membrane cells, donor3	12240-129G8	14.29	1.65	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	7.07	1.01	1.01	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	16.52	2.50	1.92	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	24.29	3.17	1.48	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	9.24	0.51	0.26	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	10.64	1.21	0.48	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	9.77	2.04	0.81	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	8.54	0.88	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	17.72	2.61	0.52	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.69	1.37	0.23	0.23
clear cell carcinoma cell line:TEN	10636-108I6	7.81	0.52	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	9.52	1.46	0.00	0.73
colon carcinoma cell line:COLO-320	10420-106C6	30.41	0.76	0.38	0.76
colon, adult, donor1	10082-102B1	34.51	4.76	2.38	0.00
colon, adult, pool1	10014-101C5	46.30	8.93	6.46	3.06
colon, fetal, donor1	10070-101I7	25.34	3.09	3.71	1.24
common myeloid progenitor CMP, donor1	12130-128D6	123.76	9.17	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	9.77	2.12	1.70	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	6.64	2.26	0.91	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	7.90	2.68	1.27	0.56
corpus callosum, adult, pool1	10042-101F6	77.61	9.40	2.76	0.77
cruciate ligament, donor2	10295-104G7	20.26	4.05	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	32.10	1.61	0.80	0.00
diencephalon, adult	10193-103E4	50.88	6.00	1.92	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	9.18	0.69	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	21.80	3.85	1.28	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	20.46	0.96	0.72	0.00
ductus deferens, adult	10196-103E7	32.39	4.98	2.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	7.20	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	19.13	5.89	1.47	0.00
dura mater, adult, donor1	10041-101F5	34.69	2.31	1.82	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	19.10	2.22	0.44	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	16.34	1.58	0.43	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	40.08	5.55	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	24.82	1.82	1.51	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	37.36	5.56	1.54	2.47
embryonic pancreas cell line:2C6	10603-108E9	40.72	9.19	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	28.83	1.68	0.67	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	20.30	2.72	0.00	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	11.58	2.89	0.48	0.32
epidermoid carcinoma cell line:A431	10426-106D3	24.90	1.11	0.56	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	14.30	1.65	0.77	0.77
epididymis, adult	10197-103E8	34.95	4.19	2.72	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	22.71	2.31	0.35	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	8.26	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	21.49	2.62	0.52	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	25.39	3.64	0.79	0.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	21.40	3.58	0.45	0.67
esophagus, adult, pool1	10015-101C6	29.84	5.31	1.91	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	26.42	6.51	1.88	1.50
eye - muscle inferior rectus, donor1	10272-104E2	60.36	14.49	2.41	2.41
eye - muscle lateral, donor2	10298-104H1	18.94	4.21	2.10	0.00
eye - muscle medial, donor2	10299-104H2	43.16	7.44	1.49	0.00
eye - muscle superior, donor2	10297-104G9	35.54	8.03	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	14.57	1.46	1.46	0.00
eye, fetal, donor1	10054-101G9	41.69	3.31	1.02	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	9.36	0.38	0.64	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	13.30	0.24	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	112.40	13.89	6.00	2.35
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	30.63	2.10	0.30	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	14.17	1.19	0.55	0.09
gall bladder, adult	10198-103E9	35.01	5.07	2.41	0.72
gamma delta positive T cells, donor1	11937-126A2	25.23	6.44	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	33.99	4.11	2.24	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	35.27	4.65	1.27	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	22.63	5.61	1.55	1.35
gastric cancer cell line:AZ521	10549-107H9	18.69	2.79	0.16	0.33
gastric cancer cell line:GSS	10560-108A2	10.07	0.92	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	16.91	4.80	1.60	0.69
giant cell carcinoma cell line:LU65	10487-107B1	5.74	0.34	0.11	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	28.83	1.82	0.84	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	20.95	3.99	2.99	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	23.12	3.06	0.42	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	21.07	2.39	1.26	0.42
glioblastoma cell line:T98G	10485-107A8	12.69	0.88	0.22	0.33
glioma cell line:GI-1	10413-106B8	14.94	1.76	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	66.33	7.29	0.73	2.92
globus pallidus, adult, donor10252	10161-103A8	81.04	9.28	3.91	0.24
globus pallidus, adult, donor10258	10367-105F7	68.46	15.06	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	33.57	4.80	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	53.84	2.45	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	17.28	1.92	0.32	0.96
hIPS +CCl2, biol_rep1	14383-156B9	9.18	1.84	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	14.63	0.46	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	10.95	3.22	0.00	0.64
hIPS, biol_rep1	14380-156B6	4.31	5.75	0.00	2.87
hIPS, biol_rep2	14381-156B7	8.92	2.06	0.00	0.69
hIPS, biol_rep3	14382-156B8	45.24	7.72	1.10	2.21
hairy cell leukemia cell line:Mo	10712-109I1	8.05	1.44	0.29	0.86
heart - mitral valve, adult	10205-103F7	26.31	3.89	0.90	0.90
heart - pulmonic valve, adult	10206-103F8	34.78	6.01	1.83	1.31
heart - tricuspid valve, adult	10207-103F9	19.98	2.50	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	40.81	4.08	0.41	0.20
heart, adult, diseased, donor1	10051-101G6	66.86	7.66	2.13	0.85
heart, adult, pool1	10016-101C7	51.51	5.98	0.69	0.23
heart, fetal, pool1	10046-101G1	48.98	6.67	3.70	1.54
hepatic mesenchymal tumor cell line:LI90	10778-110G4	20.36	3.39	1.54	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	11.89	2.38	1.19	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	12.38	1.66	0.66	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	10.68	1.58	0.49	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	10.51	1.72	1.52	0.71
hepatoma cell line:Li-7	10484-107A7	13.23	3.34	1.45	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	8.84	0.40	0.10	0.10
hippocampus - adult, donor10196	10169-103B7	77.60	10.41	6.62	2.84
hippocampus, adult, donor10252	10153-102I9	104.91	13.47	7.14	3.67
hippocampus, adult, donor10258	10374-105G5	57.76	19.92	1.00	4.48
hippocampus, newborn, donor10223	10363-105F3	41.94	10.22	1.76	3.17
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	6.10	0.61	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	13.35	0.79	0.98	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	10.66	0.51	0.25	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	30.45	1.69	0.00	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	26.08	2.58	1.03	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	20.12	3.42	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	28.61	2.34	0.00	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	40.93	2.15	1.29	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	25.02	2.92	0.83	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	12.79	1.18	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	17.20	2.57	0.48	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	22.89	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	11.42	0.78	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	11.79	1.47	0.00	2.95
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.11	1.75	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	39.52	2.10	1.15	2.48
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	37.50	3.49	0.44	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	32.48	3.50	1.50	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	39.75	1.51	1.70	2.07
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	31.83	2.73	0.91	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	35.40	1.25	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	22.86	1.96	1.31	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	23.22	1.74	1.16	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	21.22	2.09	0.90	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	13.86	1.11	0.92	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	11.98	2.85	0.29	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	7.76	1.22	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	23.94	2.82	0.70	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.92	0.95	0.63	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	25.72	3.03	0.00	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	29.99	4.14	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	37.86	4.65	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	18.47	1.54	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	14.83	1.28	0.26	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	21.20	0.76	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	15.79	3.02	0.34	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	11.35	1.45	0.00	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	11.59	0.45	0.00	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	9.76	0.98	0.49	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	31.78	3.67	0.61	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	21.18	1.65	0.00	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	35.57	3.28	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	21.71	1.81	0.00	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	17.79	1.07	0.00	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	11.93	3.58	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	21.40	2.30	1.08	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	16.43	2.42	0.00	0.27
immature langerhans cells, donor1	11904-125F5	9.20	1.70	0.73	0.73
immature langerhans cells, donor2	11905-125F6	19.80	1.58	0.79	0.79
insula, adult, pool1	10039-101F3	129.93	19.21	6.06	3.22
keratoacanthoma cell line:HKA-1	10791-110H8	30.24	7.80	1.95	0.65
kidney, adult, pool1	10017-101C8	28.74	3.20	1.30	0.90
kidney, fetal, pool1	10045-101F9	39.05	4.39	1.70	1.13
large cell lung carcinoma cell line:IA-LM	10509-107D5	45.16	5.40	0.99	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	10.09	1.38	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	23.30	2.94	0.92	0.92
left atrium, adult, donor1	10079-102A7	36.51	5.45	1.09	0.00
left ventricle, adult, donor1	10078-102A6	45.00	2.02	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	15.32	1.64	1.09	0.82
leiomyoma cell line:10964C	10569-108B2	22.99	0.72	1.08	0.72
leiomyoma cell line:15242A	10570-108B3	14.67	0.00	1.09	0.00
leiomyoma cell line:15425	10571-108B4	9.96	0.73	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	50.19	9.41	1.05	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	16.06	1.53	0.35	0.35
liposarcoma cell line:KMLS-1	10782-110G8	13.43	1.41	1.56	0.16
liposarcoma cell line:SW 872	10726-110A6	24.37	5.48	1.83	0.73
liver, adult, pool1	10018-101C9	13.94	3.24	0.97	0.81
liver, fetal, pool1	10086-102B5	23.52	5.64	0.94	1.88
locus coeruleus - adult, donor10196	10182-103D2	63.14	5.40	1.75	0.15
locus coeruleus, adult, donor10252	10165-103B3	74.56	5.91	0.74	0.37
locus coeruleus, adult, donor10258	10375-105G6	64.89	6.49	0.85	0.00
locus coeruleus, newborn, donor10223	10362-105F2	26.08	1.68	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	7.75	0.97	0.00	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	30.33	0.69	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	12.39	1.45	0.66	0.66
lung, adult, pool1	10019-101D1	28.82	2.60	1.54	0.47
lung, fetal, donor1	10068-101I5	48.23	5.99	1.43	0.57
lung, right lower lobe, adult, donor1	10075-102A3	33.45	10.54	2.75	0.46
lymph node, adult, donor1	10077-102A5	20.83	1.89	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	15.78	1.97	1.10	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	12.83	1.21	0.45	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	33.13	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	41.74	3.55	0.44	0.00
mature adipocyte, donor2	12232-129F9	37.98	2.49	0.62	0.00
mature adipocyte, donor3	12233-129G1	29.87	4.27	0.95	0.00
mature adipocyte, donor4	12234-129G2	24.48	3.42	1.05	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	39.07	5.48	0.71	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	77.83	20.30	3.38	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	114.39	15.45	7.72	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	79.42	16.20	5.08	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	32.41	1.71	0.00	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	93.49	11.48	4.73	2.36
medial temporal gyrus, adult, donor10252	10156-103A3	119.48	16.55	8.49	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	48.16	11.56	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	55.99	8.97	0.72	1.44
medulla oblongata - adult, donor10196	10174-103C3	47.38	4.54	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	60.99	8.51	2.01	1.24
medulla oblongata, adult, pool1	10038-101F2	73.06	5.47	1.47	0.24
medulla oblongata, newborn, donor10223	10361-105F1	40.27	5.55	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	16.38	0.89	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	10.27	1.10	0.24	0.12
melanoma cell line:COLO 679	10514-107E1	13.08	1.44	0.43	0.29
melanoma cell line:G-361	10465-106H6	21.99	2.99	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	13.75	2.35	1.09	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	27.32	6.17	3.52	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	29.29	4.93	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	11.66	1.07	0.31	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	10.73	1.82	0.55	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	13.25	0.83	0.83	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	13.77	2.39	0.98	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	13.29	1.73	1.16	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	20.13	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.64	1.72	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.50	2.42	0.92	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	11.94	0.93	0.00	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	10.26	1.62	0.68	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	11.52	1.71	0.71	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	8.23	1.65	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	13.01	2.21	0.55	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	11.17	0.35	1.75	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	11.64	1.84	1.22	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	12.22	1.08	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	11.17	1.45	0.72	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	11.63	1.14	0.91	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	9.65	0.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	8.97	0.90	1.94	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.03	1.66	0.35	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	11.78	1.47	2.95	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	11.16	1.43	0.86	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	16.42	0.84	0.42	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	17.35	0.91	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	13.56	1.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	17.01	1.57	0.79	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	14.79	2.77	1.23	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	13.18	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	14.55	0.68	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	22.01	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	15.29	2.32	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	16.44	2.02	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	16.06	2.01	0.67	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	13.70	1.68	0.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	25.67	1.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	16.11	1.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	19.65	1.23	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	12.46	1.72	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	14.29	3.25	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.99	1.60	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	16.36	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.61	2.72	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	9.93	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	15.42	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	1.22	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.13	1.90	1.90	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.11	1.03	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	6.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.45	1.22	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	10.33	0.79	2.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.61	1.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.78	0.94	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	2.67	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	9.46	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.82	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	14.35	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	16.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.27	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	21.76	3.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	20.27	3.80	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	18.21	5.46	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	16.47	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	8.93	0.99	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	10.71	1.95	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	12.22	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	36.36	5.42	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	15.59	1.42	0.24	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	20.39	1.62	0.93	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	18.80	1.03	0.21	0.00
mesothelioma cell line:Mero-25	10850-111F4	16.34	1.13	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	16.87	1.47	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	17.94	1.77	0.44	0.66
mesothelioma cell line:Mero-82	10853-111F7	19.18	2.63	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	18.55	2.72	0.51	0.17
mesothelioma cell line:Mero-84	10855-111F9	8.34	0.51	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	15.53	1.86	0.41	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	11.10	2.15	0.66	0.17
mesothelioma cell line:NCI-H226	10846-111E9	8.14	0.36	0.18	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	14.52	1.37	0.17	0.51
mesothelioma cell line:NCI-H28	10845-111E8	11.20	0.76	0.76	0.25
mesothelioma cell line:No36	10857-111G2	7.83	0.33	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	17.34	4.88	1.35	0.81
migratory langerhans cells, donor1	11901-125F2	25.53	5.76	0.96	1.34
migratory langerhans cells, donor2	11902-125F3	30.53	7.94	2.08	2.44
migratory langerhans cells, donor3	11903-125F4	28.18	6.82	1.26	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.34	2.29	0.33	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	11.44	1.27	0.85	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	16.36	0.69	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	9.32	1.33	0.57	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	18.66	1.66	0.18	0.18
myeloma cell line:PCM6	10474-106I6	17.99	3.76	0.79	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	25.87	3.04	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	16.08	1.18	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	14.04	1.11	0.33	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	12.65	0.15	0.15	0.15
nasal epithelial cells, donor2	12227-129F4	14.90	0.55	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	28.99	2.07	0.46	0.46
neuroblastoma cell line:NB-1	10539-107G8	23.20	2.81	0.56	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	15.18	3.37	0.84	0.42
neuroblastoma cell line:NH-12	10555-107I6	42.49	2.61	0.56	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	18.74	4.51	0.47	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	24.71	3.01	0.63	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	15.09	0.40	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	22.25	0.64	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	23.95	3.46	0.53	0.00
neutrophil PMN, donor1	12133-128D9	14.87	29.75	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	39.41	4.90	0.85	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	22.41	5.60	2.40	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	23.08	2.89	1.28	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.08	2.89	1.05	0.53
nucleus accumbens, adult, pool1	10037-101F1	100.30	14.62	5.34	3.00
occipital cortex - adult, donor10196	10172-103C1	72.11	8.24	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	136.60	20.66	8.32	2.15
occipital cortex, newborn, donor10223	10355-105E4	45.86	8.73	2.18	1.09
occipital lobe, adult, donor1	10076-102A4	81.34	10.50	4.46	0.79
occipital lobe, fetal, donor1	10073-102A1	70.37	10.73	2.57	0.86
occipital pole, adult, pool1	10036-101E9	102.97	16.00	4.10	1.18
olfactory region, adult	10195-103E6	91.13	15.86	4.59	3.25
optic nerve, donor1	10277-104E7	66.03	14.01	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	28.36	2.85	0.57	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	13.88	0.96	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	28.11	2.54	1.35	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	31.53	4.16	1.27	1.04
osteoclastoma cell line:Hs 706.T	10704-109H2	22.64	5.29	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	15.88	1.87	2.80	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	13.57	0.85	0.21	0.21
ovary, adult, pool1	10020-101D2	27.08	3.23	1.40	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	11.37	0.55	0.37	0.18
pancreas, adult, donor1	10049-101G4	31.98	2.82	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	13.42	2.80	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	20.95	4.09	0.68	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	20.53	3.15	0.50	0.33
paracentral gyrus, adult, pool1	10035-101E8	102.23	12.90	5.31	2.38
parietal cortex, adult, donor10258	10373-105G4	56.52	8.81	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	72.42	9.40	1.88	1.88
parietal lobe, adult, donor10252	10157-103A4	104.89	15.39	8.55	0.29
parietal lobe, adult, pool1	10034-101E7	110.15	14.28	6.08	2.11
parietal lobe, fetal, donor1	10072-101I9	51.40	2.91	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	47.85	7.48	0.75	0.75
parotid gland, adult	10199-103F1	31.45	4.93	1.85	1.23
penis, adult	10200-103F2	34.91	3.76	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	12.09	0.56	0.56	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	34.38	4.52	2.04	0.29
pineal gland - adult, donor10196	10179-103C8	70.95	12.90	2.58	1.94
pineal gland, adult, donor10252	10160-103A7	71.07	11.84	5.33	0.00
pineal gland, adult, donor10258	10377-105G8	55.18	6.27	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	53.63	4.05	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	64.11	8.34	2.61	1.04
pituitary gland, adult, donor10258	10378-105G9	36.60	4.26	0.00	0.00
placenta, adult, pool1	10021-101D3	31.18	4.73	0.65	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	20.00	2.25	0.79	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	12.76	1.56	0.62	0.31
pons, adult, pool1	10033-101E6	95.02	7.23	1.64	0.26
postcentral gyrus, adult, pool1	10032-101E5	111.24	13.60	5.58	1.83
promyelocytes/myelocytes PMC, donor1	12132-128D8	56.47	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	15.29	1.46	0.29	0.44
prostate cancer cell line:PC-3	10439-106E7	13.79	2.36	0.54	0.18
prostate, adult, pool1	10022-101D4	31.56	4.44	2.00	0.91
putamen, adult, donor10196	10176-103C5	104.34	18.41	9.91	2.60
putamen, adult, donor10252	10152-102I8	50.98	9.80	5.88	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	20.76	17.48	2.19	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	69.34	15.22	3.38	1.69
putamen, newborn, donor10223	10365-105F5	25.49	4.50	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	12.51	1.16	0.87	0.00
rectum, fetal, donor1	10067-101I4	48.68	4.17	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	6.57	1.06	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	17.40	2.07	0.00	0.00
retina, adult, pool1	10030-101E3	52.78	6.26	2.09	0.80
retinoblastoma cell line:Y79	10475-106I7	8.57	0.26	0.52	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.94	1.11	0.74	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	17.15	1.69	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	33.35	7.58	0.76	0.00
salivary acinar cells, donor1	11771-123I7	13.92	1.94	0.81	0.49
salivary acinar cells, donor2	11772-123I8	15.42	1.38	0.83	0.28
salivary acinar cells, donor3	11773-123I9	37.74	9.27	0.66	0.00
salivary gland, adult, pool1	10093-102C3	25.74	5.15	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	10.12	0.67	0.51	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	12.34	1.29	0.82	0.24
seminal vesicle, adult	10201-103F3	35.98	6.35	2.12	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	21.86	7.04	2.43	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	11.32	1.76	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	21.07	2.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	32.64	2.82	0.40	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	19.78	1.22	0.44	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	11.87	1.29	0.39	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	61.71	3.55	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	62.01	3.60	1.80	0.60
skeletal muscle, fetal, donor1	10066-101I3	35.18	3.02	1.01	0.00
skin, adult, donor1	10074-102A2	33.93	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	33.46	4.42	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	37.69	7.34	3.00	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	36.88	2.84	2.21	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	29.68	3.08	0.19	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	26.21	2.64	0.00	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	12.71	0.48	0.16	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	33.56	6.10	2.18	1.31
small intestine, adult, pool1	10024-101D6	63.90	13.14	7.29	3.46
small intestine, fetal, donor1	10064-101I1	21.87	3.19	2.46	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	42.57	6.15	4.62	4.10
smooth muscle, adult, pool1	10048-101G3	33.60	2.07	1.81	1.29
somatostatinoma cell line:QGP-1	10781-110G7	35.11	6.97	1.61	0.54
spinal cord - adult, donor10196	10181-103D1	44.28	3.44	1.38	0.46
spinal cord, adult, donor10252	10159-103A6	33.91	4.73	2.76	0.00
spinal cord, adult, donor10258	10369-105F9	19.37	2.77	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	50.62	5.49	1.83	0.61
spinal cord, newborn, donor10223	10359-105E8	30.77	2.30	1.38	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	21.36	4.03	2.09	0.45
spleen, adult, pool1	10025-101D7	18.72	3.08	1.10	0.66
spleen, fetal, pool1	10044-101F8	30.19	5.24	1.67	0.56
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	7.35	0.72	0.31	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	35.32	2.47	0.76	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	19.92	3.49	0.35	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	31.67	4.69	1.17	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	44.24	5.52	1.91	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	7.20	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	11.42	3.38	1.69	0.42
stomach, fetal, donor1	10062-101H8	49.13	6.41	5.34	1.07
submaxillary gland, adult	10202-103F4	29.62	6.84	2.28	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	56.50	7.27	2.08	0.62
substantia nigra, adult, donor10258	10371-105G2	51.73	5.17	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	34.62	4.95	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	13.30	2.29	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	122.58	16.78	6.61	2.54
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	74.79	7.12	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	55.38	8.35	0.88	0.88
tenocyte, donor1	11763-123H8	25.14	2.44	1.40	0.35
tenocyte, donor2	11765-123I1	15.64	5.72	1.14	0.38
tenocyte, donor3	11768-123I4	18.53	2.97	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	14.79	1.70	0.34	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	20.81	2.16	0.77	0.31
teratocarcinoma cell line:PA-1	10807-111A6	23.87	0.93	0.46	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	22.09	3.68	0.63	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	24.58	4.92	1.51	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	12.43	4.25	1.85	1.42
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	18.89	2.93	1.30	0.65
testis, adult, pool1	10026-101D8	83.21	8.70	2.36	1.61
testis, adult, pool2	10096-102C6	117.28	14.89	3.16	2.71
thalamus - adult, donor10196	10168-103B6	52.99	0.00	2.21	1.10
thalamus, adult, donor10252	10154-103A1	68.30	8.60	3.44	1.72
thalamus, adult, donor10258, tech_rep1	10370-105G1	24.63	21.55	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	54.35	5.27	1.65	0.00
thalamus, newborn, donor10223	10366-105F6	22.44	1.73	0.58	0.00
throat, adult	10209-103G2	32.21	4.24	0.75	1.00
throat, fetal, donor1	10061-101H7	39.92	4.88	1.52	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	23.65	1.79	0.40	0.40
thymus, adult, pool1	10027-101D9	49.81	5.27	2.58	1.99
thymus, fetal, pool1	10043-101F7	47.07	6.44	2.29	2.49
thyroid carcinoma cell line:KHM-5M	10776-110G2	13.69	0.40	0.40	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	27.38	2.51	1.12	0.98
thyroid, adult, pool1	10028-101E1	40.31	4.76	2.33	0.56
thyroid, fetal, donor1	10060-101H6	37.18	3.43	1.32	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	49.27	3.08	3.08	3.08
tongue, adult	10203-103F5	20.00	3.02	1.16	0.93
tongue, fetal, donor1	10059-101H5	38.62	5.12	0.79	0.00
tonsil, adult, pool1	10047-101G2	31.46	3.41	1.30	0.80
trachea, adult, pool1	10029-101E2	18.16	3.27	1.23	0.82
trachea, fetal, donor1	10058-101H4	28.47	5.00	1.92	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	17.36	2.83	1.77	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	20.47	2.13	0.51	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	18.18	2.51	0.63	0.94
tridermal teratoma cell line:HGRT	10694-109G1	39.95	3.81	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	22.01	5.25	1.44	0.76
umbilical cord, fetal, donor1	10057-101H3	16.69	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	40.44	6.65	2.05	1.19
uterus, fetal, donor1	10055-101H1	28.16	3.07	1.54	1.02
vagina, adult	10204-103F6	25.20	6.46	3.23	0.00
vein, adult	10191-103E2	28.06	3.07	1.53	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	9.35	2.14	0.53	0.27